The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N - Wikidata - awgldk - TriplyDB

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

http://www.wikidata.org/entity/Q28346061

about

Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia.Novel Phenazine 5,10-Dioxides Release OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo.Radiogenic therapy: novel approaches for enhancing tumor radiosensitivity.Impact of tumor blood flow modulation on tumor sensitivity to the bioreductive drug banoxantrone Targeting the metabolic microenvironment of tumors.Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.Androgen deprivation results in time-dependent hypoxia in LNCaP prostate tumours: informed scheduling of the bioreductive drug AQ4N improves treatment response.Beyond antiangiogenesis: intratumorally injected bevacizumab plays a cisplatin-sensitizing role in squamous cell carcinomas in mice.Tumor-selective drug activation: a GDEPT approach utilizing cytochrome P450 1A1 and AQ4N.Enhancement of the antitumor effect of cyclophosphamide with the hypoxia-selective cytotoxin NLCQ-1 against murine tumors and human xenografts.Bioreductive GDEPT using cytochrome P450 3A4 in combination with AQ4N.

P2860

Q33279493-5964B396-21A7-4454-BD50-26EC03D93B3B Q35390655-A1446211-7478-426A-B69C-9CB1EF3B168A Q36200146-CB6CF91A-E392-4F2F-9A30-B24A6BAF75BC Q36573248-6ED7AF25-EF80-48CD-B0B5-24093DA3B5BA Q37229190-6DACE30F-7F48-475D-8BF9-15099399A806 Q37426436-C9733207-1E07-4B5F-9EAB-40C42EE44B48 Q39292683-63DBD161-CAFB-4C5C-9A1E-87351D2869EA Q39539497-BCD660B3-4BE6-4E7E-8595-9425E39CC60A Q40330281-23F26E39-9B62-4BAB-AB82-8C73C6411061 Q44204636-7F27EBB4-69A0-4DF7-8B37-4D772B7B5EC0 Q51693639-2F077F4C-AC42-427E-ABFF-4E14B60CFE15

P2860

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

http://www.wikidata.org/entity/Q28346061

description

2001 nî lūn-bûn

@nan

2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@ast

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@en

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@nl

type

label

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@ast

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@en

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@nl

prefLabel

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@ast

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@en

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@nl

P1433

Q28346061-5CD87BAB-6EE3-4A11-A621-58373CEFB314

P1476

Q28346061-EDB4572A-42D9-490E-87CD-E271E4E96022

P2093

Q28346061-2625452C-8ABD-45D3-90A0-7D1F1B20600E

Q28346061-49F27891-98B1-4862-ACD1-25D57700AB85

Q28346061-77F58BC2-5691-40F1-85DF-528F710D1540

Q28346061-96A1A2EF-3FB6-424F-AF27-305145DA3D59

Q28346061-C3651575-23DA-4057-A1B9-E0E61CED8069

Q28346061-F0FDBF8A-545D-4C82-B604-43B25E119F7A

Q28346061-F2CD959B-2758-44AE-AFC3-815902C33E59

P2860

Q28346061-01139BA5-6230-46E0-AEEF-C359EE2700B4

Q28346061-0EDF573F-C615-4B4F-8130-F59DA12CF986

Q28346061-1B562675-70B5-4123-99DB-22FE02691A0C

Q28346061-437376B7-706F-4BF1-B913-707BD1932A1D

Q28346061-43DA1936-A360-45C6-BFE7-40BD8AD5AE90

Q28346061-48279C56-495B-4E00-9B6D-636C8FD9ABD5

Q28346061-5009EF27-6132-4B7E-BE70-D70A36DD7797

Q28346061-548B4C11-D2C9-4F4E-9171-E0252EB724EA

Q28346061-8615CCB3-F2F1-4C17-83C0-2B754D3FAC0A

Q28346061-95108957-C26B-495C-9ED1-6E3F07A4FB4D

P2888

Q28346061-D8DFDC3B-7CB8-414E-B4A1-D1B546809F85

P304

Q28346061-8D188F8E-95B6-4B5E-828D-C22531BB5861

P31

Q28346061-55C3ED17-AC07-47B2-8BAF-2049817FB176

P356

Q28346061-973AEDFA-6D65-4688-B7E5-610E28445EB0

P407

Q28346061-6739745A-57E5-48AE-AB28-A1487F6EC787

P433

Q28346061-4049ED76-064A-4C54-B1FF-0175368F369B

P478

Q28346061-745C4A37-C930-45B4-9ED5-80BAA54333E4

P577

Q28346061-9C97AEF3-A9B6-4DD2-979E-369D33593A31

P5875

Q28346061-1C5A69D7-916B-40F7-A66E-FA2802BB8039

P6179

Q28346061-5AA93494-7FFC-441F-9750-A6DA8D791FB1

P698

Q28346061-889A929C-FBDA-4557-8951-971F28BCBDAB

P932

Q28346061-31A653C6-D0C8-4DFB-927B-DB6E09BF197C

P356

P1433

British Journal of Cancer

P1476

The chemopotentiation of cisplatin by the novel bioreductive drug AQ4N

@en

P2093

C M Hughes

http://www.w3.org/2001/XMLSchema#string

D G Hirst

http://www.w3.org/2001/XMLSchema#string

L H Patterson

http://www.w3.org/2001/XMLSchema#string

M M Murray

http://www.w3.org/2001/XMLSchema#string

O P Friery

http://www.w3.org/2001/XMLSchema#string

R Gallagher

http://www.w3.org/2001/XMLSchema#string

S R McKeown

http://www.w3.org/2001/XMLSchema#string

P2860

Enhancement of alkylating agent activity by SR-4233 in the FSaIIC murine fibrosarcoma.

A direct measurement of the radiation sensitivity of normal mouse bone marrow cells.

Enhancement of melphalan-induced tumour cell killing by misonidazole: an interaction of competing mechanisms

DNA damage following combination of radiation with the bioreductive drug AQ4N: possible selective toxicity to oxic and hypoxic tumour cells.

Enhancement of the anti-tumour effect of cyclophosphamide by the bioreductive drugs AQ4N and tirapazamine.

Comparative chemosensitivity of exponential- versus plateau-phase cells in both in vitro model systems.

Hypoxic cells as specific drug targets for chemotherapy.

Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.

Human CYP2B6: expression, inducibility and catalytic activities.

DNA topoisomerase II-dependent cytotoxicity of alkylaminoanthraquinones and their N-oxides.

P2888

P304

625-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2001.1975

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11837799

http://www.w3.org/2001/XMLSchema#string

P6179

1023911367

http://www.w3.org/2001/XMLSchema#string

P698

11506506

http://www.w3.org/2001/XMLSchema#string

P932

2364091

http://www.w3.org/2001/XMLSchema#string